This company has been marked as potentially delisted and may not be actively trading. Boundless Bio (BOLD) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Get the Latest News and Ratings for BOLD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Boundless Bio and its competitors. Enter your email to sign up for newsletter Sign Up BOLD Analyst Ratings Over TimeTypeCurrent Forecast7/12/24 to 7/12/251 Month Ago6/12/24 to 6/12/253 Months Ago4/13/24 to 4/13/251 Year Ago7/13/23 to 7/12/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy1 Buy rating(s)1 Buy rating(s)2 Buy rating(s)3 Buy rating(s)Hold3 Hold rating(s)3 Hold rating(s)1 Hold rating(s)0 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$4.00$4.00$23.00$23.00Forecasted Upside238.98% Upside263.64% Upside1,785.25% Upside463.73% UpsideConsensus RatingHoldHoldModerate BuyBuy BOLD Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History BOLD Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Boundless Bio Stock vs. The CompetitionTypeBoundless BioMedical CompaniesS&P 500Consensus Rating Score 2.25 2.80 2.54Consensus RatingHoldModerate BuyModerate BuyPredicted Upside238.98% Upside8,633.66% Upside10.52% UpsideNews Sentiment RatingNeutral NewsSee Recent BOLD NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails6/2/2025HC Wainwright1 of 5 starsMitchell KapoorSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$5.00+354.54%5/28/2025Leerink Partners1 of 5 starsMichael ChernySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$15.00 ➝ $3.00+131.66%5/27/2025Leerink Partnrs1 of 5 starsA. BerensSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold12/13/2024GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. SchmidtSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral4/22/2024Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOverweight$20.00+98.22%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:01 AM ET. BOLD Forecast - Frequently Asked Questions What is Boundless Bio's forecast for 2025? According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Boundless Bio is $4.00, with a high forecast of $5.00 and a low forecast of $3.00. Should I buy or sell Boundless Bio stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Boundless Bio in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BOLD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BOLD, but not buy additional shares or sell existing shares. Does Boundless Bio's stock price have much upside? According to analysts, Boundless Bio's stock has a predicted upside of 238.98% based on their 12-month stock forecasts. Has Boundless Bio been downgraded by Wall Street analysts recently? Over the previous 90 days, Boundless Bio's stock had 2 downgrades by analysts. What analysts cover Boundless Bio? Boundless Bio has been rated by research analysts at HC Wainwright, Leerink Partners, and Leerink Partnrs in the past 90 days. Do Wall Street analysts like Boundless Bio more than its competitors? Analysts like Boundless Bio less than other "medical" companies. The consensus rating for Boundless Bio is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BOLD compares to other companies. Stock Forecasts and Research Tools Related Companies IO Biotech Stock Forecast Coherus Oncology Stock Forecast Elutia Stock Forecast MacroGenics Stock Forecast Virios Therapeutics Stock Forecast Corbus Pharmaceuticals Stock Forecast Nutriband Stock Forecast Zentalis Pharmaceuticals Stock Forecast OncoCyte Stock Forecast Microbot Medical Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:BOLD) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored"I'm risking my reputation on this"Most people think you need thousands to profit from crypto. But this free book exposes how even small inves...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boundless Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Boundless Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
